Neurological Surgery · Sacramento, CA
NPI
1801917554
Since 2007
Specialty
Neurological Surgery
Code 207T00000X
Group practices
1
Medicare group memberships
Hospitals
6
Hospital affiliations
2800 L St, Suite 500
Sacramento, CA, 95816
Phone (916) 454-6850
Groups this clinician bills Medicare through
Medicare paid, 2024
$563K
87,913 services
Medicare patients, 2024
576
Average age 76
Drug cost, 2024
$2.5M
5,778 prescriptions
Company payments, 2025
$669
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nicklesh Thakur was code J0585 (injection, onabotulinumtoxina, 1 unit), 77,955 times for 95 patients. In total Nicklesh Thakur billed 87,913 services in 26 codes, and Medicare paid $563K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-05-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 77,955 | 95 | $4.22 | $329K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 814 | 441 | $13.22 | $11K |
| 99214 Office E&M - Established | Office | 471 | 312 | $92.70 | $44K |
| 99215 Office E&M - Established | Office | 416 | 248 | $137.14 | $57K |
| 99213 Office E&M - Established | Office | 277 | 167 | $64.25 | $18K |
| 64616 Musculoskeletal | Office | 116 | 39 | $138.15 | $16K |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 100 | 69 | $25.63 | $2,563 |
| 64612 Musculoskeletal | Office | 87 | 28 | $159.25 | $14K |
| 95874 Musculoskeletal | Office | 82 | 27 | $67.70 | $5,551 |
| 64644 Musculoskeletal | Office | 81 | 28 | $138.49 | $11K |
| 64642 Musculoskeletal | Office | 41 | 15 | $121.21 | $4,969 |
| 99205 Office E&M - New | Office | 38 | 38 | $167.93 | $6,381 |
| 64645 Musculoskeletal | Office | 36 | 11 | $99.18 | $3,571 |
| 99204 Office E&M - New | Office | 24 | 24 | $125.58 | $3,014 |
By year: 2022 $481K for 63,816 services; 2023 $500K for 81,589 services; 2024 $563K for 87,913 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nicklesh Thakur prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 1,111 prescriptions and refills. In total Nicklesh Thakur wrote 5,778 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 1,111 | 2,353 | 281 | $45K |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 534 | 1,149 | 137 | $27K |
| Gabapentin Generic | 341 | 515 | 73 | $5,492 |
| Rytary Carbidopa/Levodopa | 287 | 443 | 45 | $287K |
| Donepezil Hcl Generic | 209 | 365 | 53 | $1,679 |
| Amantadine Amantadine Hcl | 173 | 300 | 45 | $5,293 |
| Primidone Generic | 170 | 387 | 52 | $4,672 |
| Quetiapine Fumarate Generic | 149 | 170 | 28 | $2,440 |
| Baclofen Generic | 139 | 246 | 35 | $4,116 |
| Memantine Hcl Generic | 131 | 243 | 32 | $4,426 |
| Duloxetine Hcl Generic | 112 | 231 | 27 | $3,646 |
| Propranolol Hcl Generic | 110 | 213 | 34 | $2,682 |
| Clonazepam Generic | 109 | 124 | 17 | $900 |
| Botox Onabotulinumtoxina | 104 | 290 | 37 | $182K |
| Rasagiline Mesylate Generic | 96 | 206 | 24 | $23K |
Brand drugs: 945 claims; generic drugs: 4,833 claims; opioid claims: 12.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nicklesh Thakur $669 ($669 in general payments such as food, travel and fees) from 3 companies. The largest payer was Abbvie Inc. with $303.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.